Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Cridland NA et al. | 1999 | intact cell/cell culture, HF-19 cells (normal human fibroblasts derived from fetal female lung) | magnetic field, 50/60 Hz | 2 µT–20 mT |
Bouwens M et al. | 2012 | intact cell/cell culture, Detroit 562 cells (human pharyngeal cells), THP-1 cells (human monocytic leukemia cell line) and human monocytes | magnetic field, low frequency, 50/60 Hz | 5 µT |
Rao S et al. | 1996 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | magnetic field, 50/60 Hz | 6 µT |
Lin H et al. | 1995 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 6.7 µT |
Karabakhtsian R et al. | 1994 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 8 µT |
Gold S et al. | 1994 | intact cell/cell culture, HAL cells (SV40 origin defective mutant transformed human fibroblast cell line) | magnetic field, 50/60 Hz | 8 µT |
Jin M et al. | 1997 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), two different populations: Columbia University Cancer Center (CUCC), American Type Culture Collection (ATCC) | magnetic field, 50/60 Hz | 8 µT |
Tipping DR et al. | 1999 | invertebrate, <i>Drosophila melanogaster</i> | magnetic field, 50/60 Hz | 8 µT |
Lin H et al. | 1999 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | magnetic field, 50/60 Hz | 8 µT |
Lin H et al. | 1998 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells), MCF-7, T-47D, and HTB-124 cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz | 8 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.